Spruce Biosciences at Guggenheim healthcare conference: FDA path in focus

🌐 Investing.com (Cyprus) —
Spruce Biosciences at Guggenheim healthcare conference: FDA path in focus

AI Summary

Spruce Biosciences discussed its regulatory pathway with the FDA at a Guggenheim healthcare conference. The headline does not specify which product or regulatory milestones were addressed.

Health Spruce Biosciences FDA regulatory pathway biotechnology healthcare conference

Read original source →